CurePSP
Historical collection: May 2019 · Rating details mostly from 2017. Source & context
What this organization describes
because hope matters
Mission and tagline reproduced from the source record.
Three perspectives. One record.
out of 100
out of 100
out of 100
These are the dataset’s historical numeric fields, not a current rating or a new DonorAPI.com assessment. Read the score context ↗
Revenue, expenses, and composition
Program expenses
$1,678,342.78 recorded amountFundraising expenses
$393,656.24 recorded amountAdministrative expenses
$280,509.54 recorded amount- Fundraising efficiency
- $0.16 spent per $1 raised in donations, as defined in the source.
Expense shares are displayed as percentages. Component amounts in this collection match total expenses multiplied by the source ratios; rounding can leave a small difference from the total. The source does not supply a row-specific fiscal year. Field definitions ↗
The leadership information supplied
- Recorded leader
- David Kemp
- Recorded compensation
- $200,000.00
- Recorded compensation percentage
- 8.48%
These fields do not establish the current officeholder or current compensation. The metadata does not specify the denominator of the leader compensation percentage. Read with context ↗
Inspect all 23 original source fields
Exact source strings are retained below, including numeric precision. A blank value is marked as not reported; zero remains zero.
| Source field | Original source value |
|---|---|
ascoreAccountability & transparency score | 93.0 |
categoryCategory | Health |
descriptionMission & description | CurePSP, Inc. is dedicated to increasing awareness of progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and related brain diseases; advancing research toward cure and prevention; educating healthcare professionals; and providing support, education and hope for affected persons and their families. PSP and CBD are neurodegenerative brain diseases that have no known cause, treatment or cure. They affect nerve cells that control walking, balance, mobility, vision, speech, and swallowing. Five to six people per 100,000 will develop PSP. CBD affects an estimated 2000-3000 people in United States, of whom only 500-750 are diagnosed. |
einEIN | 52-1704978 |
tot_expTotal expenses | 2357223.0 |
admin_exp_pAdministrative expense fraction | 0.11900000000000001 |
fund_effFundraising efficiency ($ per $1 raised) | 0.16 |
fund_exp_pFundraising expense fraction | 0.16699999999999998 |
program_exp_pProgram expense fraction | 0.7120000000000001 |
fscoreFinancial score | 73.55 |
leaderRecorded leader | David Kemp |
leader_compRecorded leader compensation | 200000.0 |
leader_comp_pRecorded leader compensation fraction | 0.0848 |
mottoTagline | because hope matters |
nameCharity name | CurePSP |
tot_revTotal revenue | 2704782.0 |
scoreOverall score | 80.65 |
stateState code | NY |
subcategorySubcategory | Medical Research |
sizeSource size label | small |
program_expProgram expenses | 1678342.776 |
fund_expFundraising expenses | 393656.241 |
admin_expAdministrative expenses | 280509.537 |
Source: Charity Navigator Scores Expenses Dataset, version 1, attributed to katyjqian on Kaggle. Collection: May 2019; rating details mostly from 2017. Read attribution, scope, and reuse notes.